-- 吉布森能源公司（GEI.TO）周一盘后表示，公司第一季度由盈转亏，“主要原因是支持基础实物资产的金融对冲未实现损失、季度内产生的重组成本以及更高的折旧、摊销和减值费用，部分被较低的所得税支出所抵消”。 这家石油基础设施和营销公司净亏损140万美元，而去年同期净利润为5000万美元。公司未披露每股收益。 截至3月31日的第一季度，公司调整后EBITDA为1.391亿美元，低于去年同期的1.422亿美元。公司表示，利润下降是由于“一般及行政费用增加，部分被基础设施和营销部门调整后EBITDA的增加所抵消”。 该公司还宣布派发每股0.45美元的季度股息，将于7月17日支付给截至6月29日营业结束时登记在册的股东。 首席执行官柯蒂斯·菲利普表示：“完成对肖万的收购、批准哈迪斯蒂连接项目以及我们的内部重组，是本季度推进我们在12月投资者日上提出的增长战略的关键里程碑。”他补充道：“近期的地缘政治事件进一步凸显了发展可靠的北美能源供应的重要性。吉布森的业务布局合理，能够帮助我们的客户满足这一全球能源需求。” 该公司股票在多伦多证券交易所收盘上涨0.28美元，至30.18美元。
Related Articles
Asia
Westpac's Total Capital, CET1 Capital Up Year on Year in March Quarter
Westpac Banking (ASX:WBC, NZE:WBC) total capital and Common Equity Tier 1 (CET1) capital both increased year-over-year in the March quarter, according to a Tuesday Australian bourse filing.The bank's total capital in the three months to March came in at AU$98.54 billion, up from the AU$97.14 billion it reported in the year-ago period. Its CET1 capital for the period clocked in at AU$56.94 billion, rising from the AU$55.01 billion it reported for the March 2025 quarter.Its CET1 ratio for the March quarter was 12.4%, compared with a ratio of 12.2% in the prior-year period. It reported a liquidity coverage ratio of 132% for the quarter, compared with 135% in the same period in the previous year.
$ASX:WBC$NZE:WBC
Research
Research Alert: CFRA Raises Opinion On Shares Of Gildan Activewear To Buy From Hold
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We maintain our 12-month price target of CAD98, based on 16.0x our 2026 EPS estimate and above the company's five-year average forward P/E multiple of 12.9x, reflecting our view that the company deserves an above-peer multiple. We view the recent acquisition of HanesBrands as positive and believe the company will improve Hanes' operating efficiency while capitalizing on significant synergies. GIL reported Q1 2026 results that reflect the significant impact of its HanesBrands acquisition, with revenues increasing 64% to $1.17B, $18M above estimates, while facing substantial integration-related charges. Adjusted EPS from continuing operations declined to $0.43 from $0.59, $0.08 above consensus estimates, reflecting higher share count from the acquisition and ongoing integration expenses. We now view shares more positively after a 20% decline from its 52-week high just a few months ago. Shares currently trade at 13.5x the midpoint of the company's full-year EPS guidance.
$GIL
Asia
Medibank Private Reports Policyholder Growth in Nine Months to March 31, Maintains Outlook
Medibank Private (ASX:MPL) reported policyholder growth of 22,400 in its resident private health insurance business in the nine months to March 31, up 25% from the same period a year earlier, according to a Tuesday filing with the Australian bourse.The company said the resident private health insurance industry has become more competitive in recent months, with data showing consumers increasingly prioritizing value and some participants resorting to price-led customer propositions."While no new material trends have emerged in 2026, Medibank will continue to monitor utilization given historic behavior and competitor activity as we remain disciplined," it said.Medibank maintained its fiscal 2026 guidance, saying it does not expect global events and volatility to have a direct impact on its businesses.The company's main financial exposure is through its investment portfolio, which includes about AU$188 million of investments in equities, and through movements in Australia's cash rate where it flagged a roughly AU$7 million annual impact to investment income.
$ASX:MPL